BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8055241)

  • 1. Therapy of gastrointestinal motility disorders: moving in the right direction.
    Kuemmerle JF
    Gastroenterologist; 1994 Jun; 2(2):166-73. PubMed ID: 8055241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motility disorders of the small intestine: new insights into old problems.
    Kuemmerle JF
    J Clin Gastroenterol; 2000 Dec; 31(4):276-81. PubMed ID: 11129267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional differences in the manifestation of gastrointestinal motor disorders in type 1 diabetic patients with autonomic neuropathy.
    Rosztóczy A; Róka R; Várkonyi TT; Lengyel C; Izbéki F; Lonovics J; Wittmann T
    Z Gastroenterol; 2004 Nov; 42(11):1295-300. PubMed ID: 15558439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gastrointestinal motility disorders and drugs: cholinergic, anticholinergic, adrenergic, antiadrenergic and prokinetic drugs (part I)].
    Jovanović-Mićić D; Janković S; Beleslin DB
    Srp Arh Celok Lek; 1994; 122(1-2):50-4. PubMed ID: 17972806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: molecular, pathological and therapeutic features of human enteric neuropathies.
    Di Nardo G; Blandizzi C; Volta U; Colucci R; Stanghellini V; Barbara G; Del Tacca M; Tonini M; Corinaldesi R; De Giorgio R
    Aliment Pharmacol Ther; 2008 Jul; 28(1):25-42. PubMed ID: 18410560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diseases of gastrointestinal motility. Treatment with motility-modifying substances].
    Storr M; Allescher HD
    Med Monatsschr Pharm; 2003 Aug; 26(8):260-9. PubMed ID: 12953379
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gastrointestinal motility disorders and drugs: opioids, calcium antagonists, nitrates, peptides, prostaglandins and 5-hydroxytryptaminergic drugs (part II)].
    Jovanović-Mićić D; Samardzić R; Beleslin B
    Srp Arh Celok Lek; 1994; 122(3-4):88-92. PubMed ID: 17972818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of motility measurements in managing upper gastrointestinal dysfunction.
    Snape WJ
    Gastroenterologist; 1998 Mar; 6(1):44-59. PubMed ID: 9531116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small bowel motility disorders.
    Camilleri M
    Rev Gastroenterol Mex; 1994; 59(2):120-6. PubMed ID: 7991964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In which diseases is the use of motility-active measures indicated?].
    Wienbeck M; Barnert J
    Z Gastroenterol Verh; 1990 Apr; 25():138-40. PubMed ID: 1694351
    [No Abstract]   [Full Text] [Related]  

  • 11. Gastrointestinal motility testing--a personal perspective.
    Quigley EM
    Ir Med J; 1995; 88(6):210-2. PubMed ID: 8575921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prokinetic agents--their contribution to practice of gastroenterology].
    Hep A; Dolina J
    Vnitr Lek; 2011 Sep; 57(9):693-6. PubMed ID: 21957760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motility disorders in the ICU: recent therapeutic options and clinical practice.
    Röhm KD; Boldt J; Piper SN
    Curr Opin Clin Nutr Metab Care; 2009 Mar; 12(2):161-7. PubMed ID: 19202387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal motility disorders in diabetes mellitus.
    Rothstein RD
    Am J Gastroenterol; 1990 Jul; 85(7):782-5. PubMed ID: 2196782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of intestinal motility disorders.
    Di Lorenzo C; Youssef NN
    Semin Pediatr Surg; 2010 Feb; 19(1):50-8. PubMed ID: 20123274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of prokinetics for the correction of motor and tonic digestive disorders].
    Maev IV; Samsonov AA; Karmanova EA; Ivanchenko EA
    Klin Med (Mosk); 2009; 87(3):49-53. PubMed ID: 19469257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential pharmacological approaches to management of gut motility disorders.
    Malagelada JR
    Scand J Gastroenterol Suppl; 1984; 96():111-26. PubMed ID: 6382573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prokinetics and fundic relaxants in upper functional GI disorders.
    Tack J
    Curr Opin Pharmacol; 2008 Dec; 8(6):690-6. PubMed ID: 18940266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Motility-modifying drugs].
    Storr M; Allescher HD
    Internist (Berl); 2000 Dec; 41(12):1318-24, 1326-30. PubMed ID: 11189067
    [No Abstract]   [Full Text] [Related]  

  • 20. Motility disorders of the upper gastrointestinal tract in the intensive care unit: pathophysiology and contemporary management.
    Stupak DP; Abdelsayed GG; Soloway GN
    J Clin Gastroenterol; 2012 Jul; 46(6):449-56. PubMed ID: 22469641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.